LANTERN PHARMA INC. (LTRN)
Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of STAR-001
Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of STAR-001
TWO and CrossCountry Mortgage Announce Definitive Merger Agreement
Dormant shares
Events and transactions
NamiBox Expands into AI Educational Companion Devices with NAMI COMPANION Series, Introducing a New Growth Vector in Smart Learning Hardware
Sportradar Files Its Annual Report on Form 20-F
Fermi America™ Secures $165 Million Equipment Financing Facility from CSG Investments, an Affiliate of Beal Bank USA, to Accelerate Delivery of Six SGT-800 Gas Turbines for 2028 Delivery at Project Matador
Ford Issues 2026 Proxy Statement, Sets Virtual Annual Meeting for May 14
BOSS Zhipin Continued Share Repurchase, Total Repurchases Amount to Over RMB500 million in 2026
HONEYWELL ANNUAL SHAREOWNERS MEETING SET FOR MAY 22, 2026